Aurelius completes acquisition of McKesson UK
European asset administration group Aurelius has closed the acquisition of McKesson UK, the mother or father firm of a number of healthcare companies together with LloydsPharmacy, John Bell & Croyden and AAH Prescribed drugs.
The £477 million deal, introduced in November final yr, marks the fifth accomplished transaction in lower than a yr beneath Aurelius co-investment construction.
McKesson UK contains 4 divisions — retail, digital, homecare and wholesale — and generates gross sales of greater than £5 billion a yr.
Following the deal, McKesson UK will separate from its former US-based mother or father firm, McKesson Company, performing as a “standalone” enterprise.
Aurelius stated it’ll search to leverage McKesson UK’s established market positions to “maximise the alternatives out there inside every division.”
Aurelius was suggested by Rothschild & Co. (Company Finance), PwC and FRP (Monetary), Interpath (Tax), Mayer Brown and DLA (Authorized), Cardano (Pensions), Kearney (IT) and Mansfield (Industrial).
Date printed: April 8, 2022
Subscriber content material
To get limitless entry subscribe at the moment
Already a subscriber? Login